| Financial Year |
March 31 2021 |
| Monetary Funds |
11,802,739.93 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
911,927.60 |
| Accounts Receivable |
338,668,123.03 |
| Advances to Suppliers |
114,337,297.17 |
| Other Receivables |
160,897,460.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,600,000.00 |
| Inventories |
347,743,069.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,141,792.68 |
| Total Current Assets |
979,502,410.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
151,069,102.42 |
| Investment Properties |
5,398,106.06 |
| Fixed Assetes |
236,975,523.00 |
| Under-construction Projects |
33,425,786.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,183,490.85 |
| R&D expenses |
-- |
| Goodwill |
619,425,173.44 |
| Long-Term Deferred and Prepaid Expenses |
3,766,254.05 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
2,136,709.85 |
| Sub-Total of Non-Current Assets |
1,507,329,634.90 |
| Total Assets |
2,486,832,045.88 |
| Short-Term Loans |
528,053,110.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
128,336,367.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,867,790.18 |
| Taxes Payable |
95,362,549.37 |
| Interest Payable |
157,762,288.27 |
| Dividend Payable |
6,211,091.90 |
| Other payables |
512,522,822.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
279,184,165.14 |
| Other Current Liabilities |
1,137,160.23 |
| Sub-Total of Current Liabilities |
1,601,687,827.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
809,007,671.89 |
| Deferred Income Tax Liabilities |
4,548,122.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
883,755,525.20 |
| Total Liabilities |
2,485,443,352.74 |
| Paid-In Capital(Or Share Stock) |
1,752,773,758.00 |
| Capital Surplus |
2,558,677,651.92 |
| Surplus Reserve |
32,770,164.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,312,843,206.33 |
| Minority Stockholder's Interest |
-7,077,643.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,466,336.79 |
| Owner's Equity（Stockholder's Equity） |
1,388,693.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,486,832,045.88 |
